Skip to main content
Screener/Healthcare/Biotechnology

REGN — Regeneron Pharmaceuticals, Inc.

NASDAQ
$797.47+12.61 (+1.61%)
Nasdaq 100S&P 500Large CapHealthcareLow Beta
$541.00
$859.34
$779.96
$801.44
EPS (TTM)$41.04
P/E Ratio19.43
Dividend Yield0.47%
Market Cap$81.33B
Volume416K
Prev Close$784.85
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$3.6B$727.2M$6.7589.0%20.2%
Q4 '25$3.9B$844.6M$7.8684.9%21.7%
Q3 '25$3.8B$1.5B$13.6286.1%38.9%
Q2 '25$3.7B$1.4B$12.8185.6%37.9%
Q1 '25$3.0B$808.7M$7.2784.7%26.7%
Q4 '24$3.8B$917.7M$8.0685.1%24.2%
Q3 '24$3.7B$1.3B$11.5486.8%36.0%
Q2 '24$3.5B$1.4B$12.4186.5%40.4%
Get Your Daily Market Recap